Mustafa Özdoğan, MD· @ozdogan_md · X·· 12 小时前评分70
正文 · 原文
#ESMO26 PS I wrap-up, 4 LBAs, all positive:
• INTerpath-001 RFS HR 0.58
• VOLGA EFS HR 0.51
• DeLLphi-305 OS HR 0.42 (21.1 vs 12.7 mo)
• DASL-HiCaP MFS HR 0.42
Safety definitions differ. Which one made you think most?
60 浏览 · 1 赞 · 0 转发 · 0 回复
会议摘要
LBA1按 Presidential Symposium I 对上
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgINTerpath-001
https://esmocongress.esmo.org来源：Mustafa Özdoğan, MD · x.com